Publikationen von F. Holsboer

Ditzen, C.; Tang, N.; Jastorff, A. M.; Teplytska, L.; Yassouridis, A.; Maccarrone, G.; Uhr, M.; Bronisch, T.; Miller, C. A.; Holsboer, F. et al.; Turck, C. W.: Cerebrospinal Fluid Biomarkers for Major Depression Confirm Relevance of Associated Pathophysiology. Neuropsychopharmacology 37 (4), S. 1013 - 1025 (2012)

Inkster, B.; Rao, A. W.; Ridler, K.; Filippini, N.; Whitcher, B.; Nichols, T. E.; Wetten, S.; Gibson, R. A.; Borrie, M.; Kertesz, A. et al.; Guzman, D. A.; Loy-English, I.; Williams, J.; Saemann, P. G.; Auer, D. P.; Holsboer, F.; Tozzi, F.; Muglia, P.; Merlo-Pich, E.; Matthews, P. M.: Genetic variation in GOLM1 and prefrontal cortical volume in Alzheimer's disease. Neurobiology of Aging 33 (3), S. 457 - 465 (2012)

Binder, E. B.; Holsboer, F.: Low Cortisol and Risk and Resilience to Stress-Related Psychiatric Disorders. Biological Psychiatry 71 (4), S. 282 - 283 (2012)

Knapman, A.; Kaltwasser, S. F.; Martins-de-Souza, D.; Holsboer, F.; Landgraf, R.; Turck, C. W.; Czisch, M.; Touma, C.: Increased stress reactivity is associated with reduced hippocampal activity and neuronal integrity along with changes in energy metabolism. European Journal of Neuroscience 35 (3), S. 412 - 422 (2012)

Menke, A.; Domschke, K.; Czamara, D.; Klengel, T.; Hennings, J.; Lucae, S.; Baune, B. T.; Arolt, V.; Müller-Myhsok, B.; Holsboer, F. et al.; Binder, E. B.: Genome-Wide Association Study of Antidepressant Treatment-Emergent Suicidal Ideation. Neuropsychopharmacology 37 (3), S. 797 - 807 (2012)

Thoeringer, C. K.; Henes, K.; Eder, M.; Dahlhoff, M.; Wurst, W.; Holsboer, F.; Deussing, J. M.; Moosmang, S.; Wotjak, C. T.: Consolidation of Remote Fear Memories Involves Corticotropin-Releasing Hormone (CRH) Receptor Type 1-Mediated Enhancement of AMPA Receptor GluR1 Signaling in the Dentate Gyrus. Neuropsychopharmacology 37 (3), S. 787 - 796 (2012)

Dresler, M.; Wehrle, R.; Spoormaker, V. I.; Koch, S. P.; Holsboer, F.; Steiger, A.; Obrig, H.; Sämann, P. G.; Czisch, M.: Neural correlates of dream lucidity obtained from contrasting lucid versus non-lucid REM sleep: a combined EEG/fMRI case study. Sleep 35 (7), S. 1017 - 1020 (2012)

Hartmann, J.; Wagner, K. V.; Liebl, C.; Scharf, S. H.; Wang, X. D.; Wolf, M.; Hausch, F.; Rein, T.; Schmidt, U.; Touma, C. et al.; Cheung-Flynn, J.; Cox, M. B.; Smith, D. F.; Holsboer, F.; Müller, M. B.; Schmidt, M. V.: The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stress. Neuropharmacology 62 (1), S. 332 - 339 (2012)

Knapp, R. T.; Steiner, A.; Schmidt, U.; Hafner, K.; Holsboer, F.; Rein, T.: BAG-1 diversely affects steroid receptor activity. Biochemical Journal 441, S. 297 - 303 (2012)

Wang, X.-D.; Labermaier, C.; Holsboer, F.; Wurst, W.; Deussing, J. M.; Müller, M. B.; Schmidt, M. V.: Early-life stress-induced anxiety-related behavior in adult mice partially requires forebrain corticotropin-releasing hormone receptor 1. European Journal of Neuroscience 36 (3), doi: 10.1111/j.1460-9568.2012.08148.x, S. 2360 - 2367 (2012)

Filiou, M. D.; Zhang, Y. Y.; Teplytska, L.; Reckow, S.; Gormanns, P.; Maccarrone, G.; Frank, E.; Kessler, M. S.; Hambsch, B.; Nussbaumer, M. et al.; Bunck, M.; Ludwig, T.; Yassouridis, A.; Holsboer, F.; Landgraf, R.; Turck, C. W.: Proteomics and Metabolomics Analysis of a Trait Anxiety Mouse Model Reveals Divergent Mitochondrial Pathways. Biological Psychiatry 70 (11), S. 1074 - 1082 (2011)

Webhofer, C.; Gormanns, P.; Tolstikov, V.; Zieglgänsberger, W.; Sillaber, I.; Holsboer, F.; Turck, C. W.: Metabolite profiling of antidepressant drug action reveals novel drug targets beyond monoamine elevation. Translational Psychiatry 1, e58 (2011)

Zhang, Y. Y.; Filiou, M. D.; Reckow, S.; Gormanns, P.; Maccarrone, G.; Kessler, M. S.; Frank, E.; Hambsch, B.; Holsboer, F.; Landgraf, R. et al.; Turck, C. W.: Proteomic and Metabolomic Profiling of a Trait Anxiety Mouse Model Implicate Affected Pathways. Molecular & Cellular Proteomics 10 (12), doi: 10.1074/mcp.M111.008110 (2011)

Touma, C.; Gassen, N. C.; Herrmann, L.; Cheung-Flynn, J.; Büll, D. R.; Ionescu, I. A.; Heinzmann, J. M.; Knapman, A.; Siebertz, A.; Depping, A. M. et al.; Hartmann, J.; Hausch, F.; Schmidt, M. V.; Holsboer, F.; Ising, M.; Cox, M. B.; Schmidt, U.; Rein, T.: FK506 Binding Protein 5 Shapes Stress Responsiveness: Modulation of Neuroendocrine Reactivity and Coping Behavior. Biological Psychiatry 70 (10), S. 928 - 936 (2011)

Dresler, M.; Koch, S. P.; Wehrle, R.; Spoormaker, V. I.; Holsboer, F.; Steiger, A.; Sämann, P. G.; Obrig, H.; Czisch, M.: Dreamed Movement Elicits Activation in the Sensorimotor Cortex. Current Biology 21 (21), S. 1833 - 1837 (2011)

Inkster, B.; Rao, A. W.; Ridler, K.; Nichols, T. E.; Saemann, P. G.; Auer, D. P.; Holsboer, F.; Tozzi, F.; Muglia, P.; Merlo-Pich, E. et al.; Matthews, P. M.: Structural Brain Changes in Patients with Recurrent Major Depressive Disorder Presenting with Anxiety Symptoms. Journal of Neuroimaging 21 (4), S. 375 - 382 (2011)

Refojo, D.; Schweizer, M.; Kuehne, C.; Ehrenberg, S.; Thoeringer, C.; Vogl, A. M.; Dedic, N.; Schumacher, M.; von Wolff, G.; Avrabos, C. et al.; Touma, C.; Engblom, D.; Schütz, G.; Nave, K. A.; Eder, M.; Wotjak, C. T.; Sillaber, I.; Holsboer, F.; Wurst, W.; Deussing, J. M.: Glutamatergic and Dopaminergic Neurons Mediate Anxiogenic and Anxiolytic Effects of CRHR1. Science 333 (6051), S. 1903 - 1907 (2011)

Wang, X. D.; Rammes, G.; Kraev, I.; Wolf, M.; Liebl, C.; Scharf, S. H.; Rice, C. J.; Wurst, W.; Holsboer, F.; Deussing, J. M. et al.; Baram, T. Z.; Stewart, M. G.; Müller, M. B.; Schmidt, M. V.: Forebrain CRF(1) Modulates Early-Life Stress-Programmed Cognitive Deficits. Journal of Neuroscience 31 (38), S. 13625 - 13634 (2011)

Adamczyk, M.; Fulda, S.; Pawlowski, M.; Steiger, A.; Holsboer, F.; Friess, E.: Robust and stable automatic detection of rapid-eye movements in REM sleep. Pharmacopsychiatry 44 (6), S. 283 - 283 (2011)

Avrabos, C.; Markt, P.; Sotnikov, S. V.; Holsboer, F.; Landgraf, R.; Eder, M.: Differences in intrinsic amygdalar network features between animals of the high- vs. low-anxiety-related behavior (HAB, LAB) mouse model. Pharmacopsychiatry 44 (6), S. 283 - 283 (2011)